Roche bets $4.3 billion on Spark in gene therapy move

Roche Holding AG is to buy U.S.-based Spark Therapeutics in a $4.3 billion deal that will give the Swiss drugmaker a foothold in gene therapy.

from Reuters: Health News https://ift.tt/2tCQ191
via IFTTT